Qatar's interior ministry said an explosion resulting from a "technical accident" occurred on Sunday at a factory in Ras Laffan, an industrial city north of the capital Doha that serves as the site of ...

Browse projects, edit plans, run simulations, load flood results, extract flow hydrographs, and animate time steps — all inside QGIS, without opening HEC-RAS.

• Govt increases development budget from Rs39.4bn to Rs46bn • Education ministry gets Rs36.3bn with Rs21bn for construction of Daanish schools ISLAMABAD: The federal government in its budget earmarked ...

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

Newark Mayor Ras J. Baraka won a fourth term leading New Jersey’s largest city on Tuesday, based on unofficial results. Baraka received 70.3% of the votes cast with all 173 districts reporting, ...

The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II ...

The targeted RAS inhibitor therapy daraxonrasib demonstrated the potential to improve patient outcomes over current standard treatments for patients with RAS-mutant pancreatic cancer, according to ...

The 2026 NFL Draft is over, and now it's all about analyzing each pick and how they fit. The Washington Commanders selected six players in the 2026 draft, beginning with Ohio State linebacker Sonny ...

Earlier this week, Revolution Medicines reported positive results from a global Phase III trial of its RAS‑targeting inhibitor daraxonrasib (RMC-6236) in metastatic pancreatic ductal adenocarcinoma ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.